Page 7 - பாரத் பயோடெக் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாரத் பயோடெக் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாரத் பயோடெக் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Covid: 13 opposition parties urge Centre to launch free mass vaccination drive

Covid: 13 opposition parties urge Centre to launch free mass vaccination drive
Covid: 13 opposition parties urge Centre to launch free mass vaccination drive
Last Updated: Mon, May 3rd, 2021, 11:01:37hrs
New Delhi: Leaders of 13 opposition parties including the Congress, Left and the Trinamool Congress have come together and called upon the central government to ensure supply of uninterrupted oxygen flow to all the hospitals and launch a free mass vaccination drive across the country in view of the unprecedented surge in COVID-19 cases.
In a joint statement which was tweeted by Congress leader Jairam Ramesh, senior leaders including Congress president Sonia Gandhi, Trinamool Congress chief Mamata Banerjee and CPM general secretary Sitaram Yechury said: Hope the Prime Minister will consider this joint statement from Opposition leaders seriously and in the right spirit. Meeting them immediately would be a good first step to rebuild trust and confidence during th ....

Jammu And Kashmir , Mamata Banerjee , Covishield Oxford Astrazeneca , Farooq Abdullah , Uddhav Thackeray , Deve Gowda , Jairam Ramesh , Akhilesh Yadav , Tejashwi Yadav , Sonia Gandhi , Hemant Soren , Sitaram Yechury , Sharad Pawar , Bharat Biotech , Jammu Kashmir People Alliance , Trinamool Congress , Serum Institute Of India , Prime Minister , Maharashtra Chief Minister , Shiv Sena , Jharkhand Chief Minister Hemant Soren , Jammu Kashmir People , Serum Institute , Bharat Biotech Limited , ஜம்மு மற்றும் காஷ்மீர் , மாமத பானர்ஜி ,

Pfizer in talks with India over expedited approval for COVID-19 vaccine: CEO

ANI |
Updated: May 03, 2021 14:38 IST
New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India.
Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Bourla, in a LinkedIn post, on Monday.
We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.
Pfizer group is committed to being a partner in India s fight against this disease and is quickly working to mobilize the largest humanitarian relief effort in our company s history, he added. ....

Covishield Oxford Astrazeneca , Albert Bourla , Bharat Biotech , Serum Institute Of India , New Delhi , Serum Institute , Bharat Biotech Limited , Pfizer Group , Albert Bourla , Onation Of Medicines , Covid 19 , Covid Vaccination , Ndia Covid Vaccination , பாரத் பயோடெக் , சீரம் நிறுவனம் ஆஃப் இந்தியா , புதியது டெல்ஹி , சீரம் நிறுவனம் , பாரத் பயோடெக் வரையறுக்கப்பட்டவை ,

Pfizer in talks with India over approval for vaccine

Pfizer in talks with India over approval for vaccine
ANI
03 May 2021, 19:18 GMT+10
New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19 vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India.
Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Bourla, in a LinkedIn post, on Monday.
We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.
Pfizer group is committed to being a partner in India s fight against this disease and is quickly working to mobilize the largest humanitarian relief effort in our company s history, he added. ....

Covishield Oxford Astrazeneca , Albert Bourla , Bharat Biotech , Serum Institute Of India , New Delhi , Serum Institute , Bharat Biotech Limited , Russia News , Ourla Said , Approval Pathway , The Indian , Edicines Worth , பாரத் பயோடெக் , சீரம் நிறுவனம் ஆஃப் இந்தியா , புதியது டெல்ஹி , சீரம் நிறுவனம் , பாரத் பயோடெக் வரையறுக்கப்பட்டவை , ரஷ்யா செய்தி ,

Nearly 60 lakh vaccine doses in addition will be received by states/UTs in next 3 days: Govt

Representative Image
Nearly 60 lakh vaccine doses in addition will be received by states/UTs in next 3 days: Govt
ANI |
Updated: May 03, 2021 13:05 IST
New Delhi [India], May 3 (ANI): An additional 60 lakh COVID-19 vaccine doses will be received by the states/union territories in the next three days, the central government informed on Monday.
In a media release, the health ministry said the government of India has so far provided nearly 16.54 crore vaccine doses (16,54,93,410) to states/union territories free of cost. Of this, the total consumption including wastages is 15,79,21,537 doses (as per data available at 8 am on Monday).
More than 75 lakh COVID vaccine doses (75,71,873) are still available with the states/union territories to be administered. Furthermore, more than 59 lakh (59,70,670) vaccine doses will be received in addition by the states/union territories within the next three days, the release stated. ....

New Delhi , Covishield Oxford Astrazeneca , Centre On , Bharat Biotech , Serum Institute Of India , Serum Institute , Bharat Biotech Limited , Union Health Ministry , Covid 19 , Covid Vaccine , Covid Vaccination , புதியது டெல்ஹி , மையம் ஆன் , பாரத் பயோடெக் , சீரம் நிறுவனம் ஆஃப் இந்தியா , சீரம் நிறுவனம் , பாரத் பயோடெக் வரையறுக்கப்பட்டவை , தொழிற்சங்கம் ஆரோக்கியம் அமைச்சகம் ,

Nearly 60 lakh vaccine doses in addition to be received by states/UTs: Govt

An additional 60 lakh COVID-19 vaccine doses will be received by the states/union territories in the next three days, the central government informed on Monday.
In a media release, the health ministry said the government of India has so far provided nearly 16.54 crore vaccine doses (16,54,93,410) to states/union territories free of cost. Of this, the total consumption including wastages is 15,79,21,537 doses (as per data available at 8 am on Monday).
More than 75 lakh COVID vaccine doses (75,71,873) are still available with the states/union territories to be administered. Furthermore, more than 59 lakh (59,70,670) vaccine doses will be received in addition by the states/union territories within the next three days, the release stated. ....

Covishield Oxford Astrazeneca , Centre On , Bharat Biotech , Serum Institute Of India , Serum Institute , Bharat Biotech Limited , Covid 19 , Covid 19 Vaccines , Accine Does To States , Accine Doses To Uts , Coronavirus Vaccines , மையம் ஆன் , பாரத் பயோடெக் , சீரம் நிறுவனம் ஆஃப் இந்தியா , சீரம் நிறுவனம் , பாரத் பயோடெக் வரையறுக்கப்பட்டவை , விட் தடுப்பு மருந்துகள் ,